Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. ACST.NASDAQ

Acasti Pharma Inc (ACST NASDAQ) stock market data APIs

$2.8 0.04(1.4%) as of July 26, 2024
Price chart is built with Anychart

Acasti Pharma Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey.

Acasti Pharma Inc Financial Data Overview

2.76
2.8
-
2.8657
2.69
1.72-3.59
26 600 K
9 399 K
115 K
-0.18
1.548
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'ACST',
Type: 'Common Stock',
Name: 'Acasti Pharma Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG001NMDXS6',
ISIN: 'CA00430K8730',
CUSIP: '00430K105',
CIK: NULL,
EmployerIdNumber: '',
FiscalYearEnd: 'March',
IPODate: '2011-05-06',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'ADR',
IsDelisted: false,
}

Acasti Pharma Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 115 K
  • EBITDA -11 266 000
  • Earnings Per Share -1.73
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Acasti Pharma Inc Earnings via APIs

  • Latest Release 2024-06-21
  • EPS/Forecast -0.48

Get Acasti Pharma Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Acasti Pharma Inc latest news via APIs

12 Best Biotech Penny Stocks to Invest In

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these stocks, go directly to 5 Best Biotech Penny Stocks to Invest In. The past...

Acasti Announces Second Quarter 2024 Financial Results and Business Highlights

Announced Dosing of First Patient in Pivotal STRIVE-ON Phase 3 Randomized Trial for GTX-104 Completed $7.5 Million Private Placement Equity Financing led by ADAR1 Partners, LP, Providing Funding Well ...
  • ACASTI PHARMA
  • EARNINGS RELEASES AND OPERATING RESULTS
  • INC
  • NASDAQ:ACST
Do you have any questions?
support@eodhistoricaldata.com